Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2021-2026
  • ID: 100089
  • February 3, 2021
  • 135 pages
  • LP Information

According to this latest study, the 2020 growth of Neuromodulation Devices and Implantable Infusion Pumps will have significant change from previous year. By the most conservative estimates of global Neuromodulation Devices and Implantable Infusion Pumps market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Neuromodulation Devices and Implantable Infusion Pumps market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Parkinson's Disease
Epilepsy
Pain
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption 2016-2026
2.1.2 Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial Magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2016-2021)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2016-2021)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2016-2021)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2016-2021)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2016-2021)

3 Global Neuromodulation Devices and Implantable Infusion Pumps by Company
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2019-2021)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2019-2021)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2019-2021)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2019-2021)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Global Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Neuromodulation Devices and Implantable Infusion Pumps by Region
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps by Region
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region
4.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth

5 Americas
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
10.3 Neuromodulation Devices and Implantable Infusion Pumps Customer

11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast
11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region
11.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions (2021-2026)
11.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
11.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application

12 Key Players Analysis
12.1 Medtronic
12.1.1 Medtronic Medtronic Company Information
12.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Medtronic Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Company Information
12.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Boston Scientific Corporation Main Business Overview
12.2.5 Boston Scientific Corporation Latest Developments
12.3 Abbott
12.3.1 Abbott Company Information
12.3.2 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Abbott Main Business Overview
12.3.5 Abbott Latest Developments
12.4 Synapse Biomedical
12.4.1 Synapse Biomedical Company Information
12.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Synapse Biomedical Main Business Overview
12.4.5 Synapse Biomedical Latest Developments
12.5 Nevro Corporation
12.5.1 Nevro Corporation Company Information
12.5.2 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Nevro Corporation Main Business Overview
12.5.5 Nevro Corporation Latest Developments
12.6 Neuropace
12.6.1 Neuropace Company Information
12.6.2 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Neuropace Main Business Overview
12.6.5 Neuropace Latest Developments
12.7 Cyberonics
12.7.1 Cyberonics Company Information
12.7.2 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Cyberonics Main Business Overview
12.7.5 Cyberonics Latest Developments
12.8 Autonomic Technologies
12.8.1 Autonomic Technologies Company Information
12.8.2 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Autonomic Technologies Main Business Overview
12.8.5 Autonomic Technologies Latest Developments
12.9 Avery Biomedical
12.9.1 Avery Biomedical Company Information
12.9.2 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Avery Biomedical Main Business Overview
12.9.5 Avery Biomedical Latest Developments
12.10 Greatbatch Medical
12.10.1 Greatbatch Medical Company Information
12.10.2 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Greatbatch Medical Main Business Overview
12.10.5 Greatbatch Medical Latest Developments

13 Research Findings and Conclusion

None

None

List of Tables
Table 1. Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Spinal Cord Stimulation
Table 3. Major Players of Deep Brain Stimulation
Table 4. Major Players of Sacral Nerve Stimulation
Table 5. Major Players of Vagal Nerve Stimulation
Table 6. Major Players of Gastric Stimulation
Table 7. Major Players of Transcranial Magnetic Stimulation
Table 8. Major Players of Transcutaneous Electrical Stimulation
Table 9. Major Players of Other
Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & ($ million)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2021)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2016-2021)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Value by Application (2016-2021)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2021)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2016-2021)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2019-2021) & (K Units)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2019-2021)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2019-2021) ($ Millions)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2019-2021)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2019-2021)
Table 25. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution and Sales Area
Table 26. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 27. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) (K Units)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021) & ($ Millions)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2016-2021)
Table 34. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 35. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2016-2021)
Table 36. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & ($ Millions)
Table 37. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2016-2021)
Table 38. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 39. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 40. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 41. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 42. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) & (K Units)
Table 43. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
Table 44. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021) & ($ Millions)
Table 45. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2016-2021)
Table 46. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 47. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 48. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 49. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2016-2021)
Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & ($ Millions)
Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2016-2021)
Table 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 57. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 58. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 59. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2016-2021)
Table 60. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & ($ Millions)
Table 61. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2016-2021)
Table 62. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 63. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2021)
Table 64. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 65. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2021-2026) & (K Units)
Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2021-2026)
Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Type (2021-2026)
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2021-2026) & (K Units)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Application (2021-2026)
Table 72. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 73. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share Forecast by Application (2021-2026)
Table 74. Medtronic Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 75. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 76. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 77. Medtronic Main Business
Table 78. Medtronic Latest Developments
Table 79. Boston Scientific Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 80. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 81. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 82. Boston Scientific Corporation Main Business
Table 83. Boston Scientific Corporation Latest Developments
Table 84. Abbott Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 85. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 86. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 87. Abbott Main Business
Table 88. Abbott Latest Developments
Table 89. Synapse Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 91. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 92. Synapse Biomedical Main Business
Table 93. Synapse Biomedical Latest Developments
Table 94. Nevro Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 96. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 97. Nevro Corporation Main Business
Table 98. Nevro Corporation Latest Developments
Table 99. Neuropace Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 101. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 102. Neuropace Main Business
Table 103. Neuropace Latest Developments
Table 104. Cyberonics Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 106. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 107. Cyberonics Main Business
Table 108. Cyberonics Latest Developments
Table 109. Autonomic Technologies Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 111. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 112. Autonomic Technologies Main Business
Table 113. Autonomic Technologies Latest Developments
Table 114. Avery Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 115. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 116. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 117. Avery Biomedical Main Business
Table 118. Avery Biomedical Latest Developments
Table 119. Greatbatch Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 121. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 122. Greatbatch Medical Main Business
Table 123. Greatbatch Medical Latest Developments
List of Figures
Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Spinal Cord Stimulation
Figure 10. Product Picture of Deep Brain Stimulation
Figure 11. Product Picture of Sacral Nerve Stimulation
Figure 12. Product Picture of Vagal Nerve Stimulation
Figure 13. Product Picture of Gastric Stimulation
Figure 14. Product Picture of Transcranial Magnetic Stimulation
Figure 15. Product Picture of Transcutaneous Electrical Stimulation
Figure 16. Product Picture of Other
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2021)
Figure 19. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's Disease
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's Disease (2016-2021) & (K Units)
Figure 21. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2016-2021) & (K Units)
Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Pain
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2016-2021) & (K Units)
Figure 25. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2016-2021) & (K Units)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2021)
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2020
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market by Company in 2020 ($ Million)
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2020
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Regions (2016-2021)
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region in 2020
Figure 33. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2021 (K Units)
Figure 34. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue 2016-2021 ($ Millions)
Figure 35. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2021 (K Units)
Figure 36. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue 2016-2021 ($ Millions)
Figure 37. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2021 (K Units)
Figure 38. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2021 (K Units)
Figure 40. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue 2016-2021 ($ Millions)
Figure 41. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2020
Figure 42. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2020
Figure 43. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 45. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2020
Figure 50. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions in 2020
Figure 51. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 52. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 53. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 57. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2020
Figure 60. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2020
Figure 61. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 62. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 63. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 64. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2020
Figure 69. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020
Figure 71. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2020
Figure 72. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles

None

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team